Niagen Bioscience, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $26.8m $21.2m $31.6m $46.3m $59.3m $67.4m $72.0m $83.6m $99.6m $129.4m
Cost of Goods and Services Sold $14.9m $10.7m $15.5m $20.5m $24.0m $26.0m $29.3m $32.8m $38.0m $46.2m
Gross Profit $11.9m $10.5m $16.1m $25.8m $35.3m $41.5m $42.8m $50.8m $61.6m $83.2m
Operating Expenses $14.2m $26.9m $49.2m $57.1m $55.1m $68.6m $61.4m $56.4m $53.9m $66.9m
Operating Income (Loss) ($2.2m) ($16.4m) ($33.2m) ($31.3m) ($19.9m) ($27.1m) ($18.6m) ($5.6m) $7.7m $16.3m
Additional Financial Items
Amortization of Intangible Assets $88k $206k $235k $246k $243k $225k $186k $158k $151k $173k
Gain (Loss) Related to Litigation Settlement ($746k) ($746k) $2.0m
Goodwill, Impairment Loss $0
Income (Loss) from Continuing Operations before Income Taxes, Domestic $18.2m
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest ($2.9m) ($16.5m) $8.9m $18.2m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent ($16.5m) ($33.3m) $0 $0 $0 $0
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $5.2m $0 $0 $0 $0 $0
Net Income (Loss) Attributable to Parent ($2.9m) ($11.4m) ($33.3m) ($32.1m) ($19.9m) ($27.1m) ($16.5m) ($4.9m) $8.6m $17.4m
Earnings Per Share, Basic ($0.40) ($0.24) ($0.07) $0.11 $0.22
Earnings Per Share, Diluted ($0.03) ($0.26) ($0.61) ($0.56) ($0.33) ($0.40) ($0.24) ($0.07) $0.11 $0.20
Weighted Average Number of Shares Outstanding, Basic 37.3m 67.2m 69.7m 75.0m 75.9m 79.2m
Weighted Average Number of Shares Outstanding, Diluted 67.2m 69.7m 75.0m 78.1m 85.4m
Research and Development Expense $2.5m $4.0m $5.5m $4.4m $3.7m $3.8m $4.8m $5.0m $6.0m $6.3m
General and Administrative Expense $9.4m $17.6m $27.1m $34.3m $30.4m $36.4m $28.3m $25.0m $18.4m $27.1m
Current Income Tax Expense (Benefit) $810k
Interest Expense $372k $153k $79k $847k $71k $55k
Operating Lease, Expense $663k $501k $1.1m $1.3m $1.2m $1.3m $1.3m
Other Expenses $746k $75k $125k $0
Selling and Marketing Expense $2.3m $4.5m $16.5m $18.2m $20.9m $28.4m $28.3m $26.4m $29.5m $35.5m
Selling Expense $9.8m $11.3m
Share-based Payment Arrangement, Expensed and Capitalized, Amount $1.3m
Income Tax Expense (Benefit) $0 $0 $305k $810k
Interest Income (Expense), Net $3k $661k
Interest Income (Expense), Nonoperating, Net $1.1m $1.9m